Tag: Abbott Lifts 2012 Forecast

Abbott Lifts 2012 Forecast

April 24, 2012

Abbott Laboratories reported better-than-expected quarterly sales and earnings, fueled by strong demand for its Humira arthritis drug and its wide array of prescription medicines, nutritional products and medical devices. The company earned $1.24 billion, or 78 cents per share, in […]

Continue Reading